Liu JH - Search Results

1

Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.

Xiong Y, Liang LZ, Cao LP, Min Z, Liu JH. Xiong Y, et al. Among authors: liu jh. Gynecol Oncol. 2011 Oct;123(1):99-104. doi: 10.1016/j.ygyno.2011.06.011. Epub 2011 Jul 8. Gynecol Oncol. 2011. PMID: 21741694

2

[Phase II clinical study of topotecan hydrochloride in patients with recurrent advanced ovarian cancer].

Li JD, Guan ZZ, Liu JH, Xin XY, Cui Y, Huang CJ, Liu FY, Song L, Bian ML, Zhou QH. Li JD, et al. Among authors: liu fy, liu jh. Ai Zheng. 2002 Apr;21(4):416-20. Ai Zheng. 2002. PMID: 12452024 Clinical Trial. Chinese.

3

[Analysis of risk factors for epithelial ovarian cancer recurrence].

Liu S, Liu JH, Huang H, Peng XP, Wang YM. Liu S, et al. Among authors: liu jh. Ai Zheng. 2003 Nov;22(11):1197-200. Ai Zheng. 2003. PMID: 14613652 Chinese.

4

[Study of different surgeries for clinical stage I endometrial carcinoma].

Li MD, Huang YW, Huang H, Liu JH. Li MD, et al. Among authors: liu jh. Zhonghua Fu Chan Ke Za Zhi. 2004 Mar;39(3):156-8. Zhonghua Fu Chan Ke Za Zhi. 2004. PMID: 15130371 Chinese.

5

[Sentinel lymph node identification with methylene blue in cervical cancer].

Yuan SH, Liang LZ, Liu JH, Zhang HZ, Xiong Y, Yan XJ, Wei M, Zhang CQ. Yuan SH, et al. Among authors: liu jh. Ai Zheng. 2004 Sep;23(9):1089-92. Ai Zheng. 2004. PMID: 15363209 Chinese.

6

[Recurrence risk factors of platinum-sensitive epithelial ovarian cancer].

Yan XJ, Liang LZ, Zeng ZY, Liu JH, Yuan SH, Wei M. Yan XJ, et al. Among authors: liu jh. Ai Zheng. 2005 Jun;24(6):751-4. Ai Zheng. 2005. PMID: 15946495 Chinese.

7

[Analysis of recurrence pattern and prognosis of patients with cervical carcinoma and pelvic lymph node metastasis].

Xiong Y, Liang LZ, Zheng M, Wang LH, Deng PF, Liu JH. Xiong Y, et al. Among authors: liu jh. Zhonghua Fu Chan Ke Za Zhi. 2008 Jun;43(6):425-8. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19035136 Chinese.

8

Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.

Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX, Guan XY. Yang GF, et al. Among authors: liu jh. Gynecol Oncol. 2009 Feb;112(2):314-8. doi: 10.1016/j.ygyno.2008.10.024. Epub 2008 Dec 2. Gynecol Oncol. 2009. PMID: 19054548

9

[Prognostic value of serum CA(125) level change during chemotherapy post-surgery in patients with advanced epithelial ovarian carcinoma].

Lan CY, Huang H, Liu JH. Lan CY, et al. Among authors: liu jh. Zhonghua Fu Chan Ke Za Zhi. 2008 Oct;43(10):732-6. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19087537 Chinese.

10

Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis.

Huang L, Zheng M, Liu JH, Xiong Y, Ding H, Tang L, Wang HY. Huang L, et al. Among authors: liu jh. Chin J Cancer. 2010 Apr;29(4):431-5. doi: 10.5732/cjc.009.10360. Chin J Cancer. 2010. PMID: 20346221 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,315 results

Search Page

Filters